Ute Mercker
Directeur/Bestuurslid bij OMEICOS Therapeutics GmbH
Profiel
Ute Mercker is currently an Investment Director at IBB Beteiligungsgesellschaft mbH since 1997 and a Director at OMEICOS Therapeutics GmbH since 2015.
Previously, she held positions as Vice Chairman-Supervisory Board at Scienion AG, Director at Humedics GmbH, and Member-Supervisory Board at GenPat77 Pharmacogenetics AG.
Ms. Mercker holds an MBA from Freie Universität Berlin.
Actieve functies van Ute Mercker
Bedrijven | Functie | Begin |
---|---|---|
IBB Beteiligungsgesellschaft mbH
IBB Beteiligungsgesellschaft mbH Investment ManagersFinance IBB Beteiligungsgesellschaft mbH (IBB Ventures) is the wholly-owned venture capital subsidiary of Investitionsbank Berlin. The firm was founded in 1997 to foster the development of regional businesses in selected areas and to strengthen the local labor market. The firm is headquartered in Berlin, Germany. | Private Equity Investor | 01-11-1997 |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Directeur/Bestuurslid | 01-03-2015 |
Eerdere bekende functies van Ute Mercker
Bedrijven | Functie | Einde |
---|---|---|
GenPat77 Pharmacogenetics AG
GenPat77 Pharmacogenetics AG Miscellaneous Commercial ServicesCommercial Services GenPat77 Pharmacogenetics AG researches and develops immune modulatory therapeutics for immune mediated diseases. The company was founded in 1998 and is headquartered in Berlin, Germany. | Directeur/Bestuurslid | 30-07-2008 |
Scienion AG
Scienion AG BiotechnologyHealth Technology Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany. | Directeur/Bestuurslid | - |
Humedics GmbH
Humedics GmbH Packaged SoftwareTechnology Services Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany. | Directeur/Bestuurslid | - |
Opleiding van Ute Mercker
Freie Universität Berlin | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
IBB Beteiligungsgesellschaft mbH
IBB Beteiligungsgesellschaft mbH Investment ManagersFinance IBB Beteiligungsgesellschaft mbH (IBB Ventures) is the wholly-owned venture capital subsidiary of Investitionsbank Berlin. The firm was founded in 1997 to foster the development of regional businesses in selected areas and to strengthen the local labor market. The firm is headquartered in Berlin, Germany. | Finance |
GenPat77 Pharmacogenetics AG
GenPat77 Pharmacogenetics AG Miscellaneous Commercial ServicesCommercial Services GenPat77 Pharmacogenetics AG researches and develops immune modulatory therapeutics for immune mediated diseases. The company was founded in 1998 and is headquartered in Berlin, Germany. | Commercial Services |
Humedics GmbH
Humedics GmbH Packaged SoftwareTechnology Services Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany. | Technology Services |
Scienion AG
Scienion AG BiotechnologyHealth Technology Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany. | Health Technology |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Health Technology |